Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22211090 | 0.94 | MEN1 (0.50) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22211108 | 0.94 | ALDH1A1 (0.36) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22211093 | 0.94 | MEN1 (0.50) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22211082 | 0.94 | MEN1 (0.50) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22211121 | 0.93 | MEN1 (0.49) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22211119 | 0.93 | MEN1 (0.49) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22211100 | 0.93 | MEN1 (0.49) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22222780 | 0.93 | MEN1 (0.37) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22211085 | 0.91 | MEN1 (0.50) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22211112 | 0.91 | MEN1 (0.50) | MEN1KMT2AALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873293-B2 | Organic molecules for optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11873293-B2 | Organic molecules for optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11384070-B2 | Organic molecules for optoelectronic devices | CYNORA GMBH (DE) | 2022-07-12 | — | — | US | disclosed |
| US-20200223831-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-16 | — | — | US | disclosed |
| EP-3680239-A1 | PHENAZINE COMPOUNDS FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200223831-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | XDH, OR10J3, C1S | MEN1 2542/4885KMT2A 4068/4885ALDH1A1 3850/4885 |
| US-11873293-B2 | Organic molecules for optoelectronic devices | XDH, C1S, OR10J3 | MEN1 2152/4885KMT2A 4078/4885ALDH1A1 3817/4885 |
| US-11384070-B2 | Organic molecules for optoelectronic devices | XDH, C1S, OR10J3 | MEN1 2306/4885KMT2A 4113/4885ALDH1A1 3831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.